CompletedNCT00205660
Weight and metabolism when continuing treatment or switching to aripiprazole in schizophrenia
About this title
Read the official source — NCT00205660Interventional studyAges 18–60United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- St LouisSee all locations and recruitment
Study information
Study start dateFebruary 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 51
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00205660
- Official title
Show the full official title
Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St Louis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Washington University School of Medicine, a university.
Who was this study for?
Listed age limits: 18 years to 60 years.
